Thiophenes
eMolecules 6164-79-0 | methyl pyrazine-2-carboxylate | Pharmablock | MFCD00014611 | 138.126 | C6H6N2O2 | 97.000 | COC(=O)c1cnccn1 | 5g | 596114927
methyl pyrazine-2-carboxylate | Pharmablock | 6164-79-0 | MFCD00014611 | 138.126 | C6H6N2O2 | 97.000 | COC(=O)c1cnccn1 | 5g | 596114927
![eMolecules 1013-23-6 | Dibenzo[b,d]thiophene 5-oxide | ChemScene | MFCD00046902 | 200.260 | C12H8OS | 96.000 | O=s1c2ccccc2c2ccccc12 | 25g | 711937355](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000473679.jpg-250.jpg)
eMolecules 1013-23-6 | Dibenzo[b,d]thiophene 5-oxide | ChemScene | MFCD00046902 | 200.260 | C12H8OS | 96.000 | O=s1c2ccccc2c2ccccc12 | 25g | 711937355
Dibenzo[b,d]thiophene 5-oxide | ChemScene | 1013-23-6 | MFCD00046902 | 200.260 | C12H8OS | 96.000 | O=s1c2ccccc2c2ccccc12 | 25g | 711937355
Selleck Chemical LLC 1400W 2HCl
1400W (N-(3-(Aminomethyl)benzyl)acetamidine) is a slow tight binding and highly selective inhibitor of inducible nitric-oxide synthase(iNOS)
Medchemexpress LLC Bisantrene dihydrochloride | 71439-68-4 | 98.9% | 471.39 g/mol | C22H24Cl2N8 | 5 MG
Bisantrene dihydrochloride is an anthracycline-class antitumor compound used in preclinical research. It intercalates into DNA, inhibits eukaryotic type II topoisomerases, and has demonstrated cytotoxic activity across multiple experimental tumor models. The material is provided as a solid for laboratory use with manufacturer storage and solubility guidance for solution preparations.
Aobchem (3-Bromo-2-fluoro-6-(methylthio)phenyl)boronic acid | 97% | C7H7BBrFO2S | 250mg
(3-Bromo-2-fluoro-6-(methylthio)phenyl)boronic acid | 97% | C7H7BBrFO2S | 250mg
eMolecules 6164-79-0 | Methyl 2-Pyrazinecarboxylate | AA Blocks LLC | MFCD00014611 | 138.126 | C6H6N2O2 | 0.000 | COC(=O)c1cnccn1 | 5g | 410181915
Methyl 2-Pyrazinecarboxylate | AA Blocks LLC | 6164-79-0 | MFCD00014611 | 138.126 | C6H6N2O2 | 0.000 | COC(=O)c1cnccn1 | 5g | 410181915
eMolecules 4934-99-0 | Methyl 3-hydroxycyclobutanecarboxylate | Synthonix - Stock | MFCD00512755 | 130.143 | C6H10O3 | 97.000 | COC(=O)C1CC(O)C1 | 10g | 525919475
Methyl 3-hydroxycyclobutanecarboxylate | Synthonix - Stock | 4934-99-0 | MFCD00512755 | 130.143 | C6H10O3 | 97.000 | COC(=O)C1CC(O)C1 | 10g | 525919475
Medchemexpress LLC Minaprine dihydrochloride | 25953-17-7 | 99.9% | 1 ML
Minaprine dihydrochloride | 25953-17-7 | 99.9% | 1 ML
Medchemexpress LLC 4-aminobenzo-12-crown-4 | 78554-68-4 | 98.0% | C12H17NO4 | 500 MG
4-Aminobenzo-12-crown-4 is a drug intermediate for the synthesis of various active compounds. It is supplied as a light brown to brown solid.
- Drug intermediate for synthesis
- Light brown to brown solid appearance
- Research reagent not for medical, clinical diagnostic, or food use
Apexbio Technology LLC Canertinib dihydrochloride 289499-45-2 100mg
Canertinib dihydrochloride (CAS 289499-45-2) is a small-molecule inhibitor targeting the pan-ErbB family of receptor tyrosine kinases It is designed to irreversibly inhibit ErbB receptors thereby disrupting Akt and MAPK signaling pathways Canertinib dihydrochloride exerts its biological activity primarily through irreversible binding to ErbB receptor family members In cell-based studies Canertinib dihydrochloride demonstrates apoptotic induction and reduced cell viability with an IC50 value of 3 5 nM Apoptosis induction was observed in BT474 (ErbB2-overexpressing breast cancer) and SK-N-SH (neuroblastoma) cell lines Based on these pharmacological properties Canertinib dihydrochloride holds research potential in oncology specifically for investigating ErbB signaling pathways and evaluating anti-tumor effects in cancer models
Apexbio Technology LLC Pramipexole 2HCl Monohydrate 191217-81-9 50mg
Pramipexole 2HCl Monohydrate is a synthetic non-ergoline dopamine receptor agonist targeting dopamine receptor subtypes particularly D3 D2S D2L and D4 It is designed to activate these receptors thereby modulating dopaminergic transmission pathways Pramipexole 2HCl Monohydrate exerts its biological activity primarily through selective receptor activation Based on these pharmacological properties Pramipexole 2HCl Monohydrate holds research potential in studies of receptor-ligand interactions receptor subtype functional analysis and dopamine-related neurologic or psychiatric disorders including Parkinson s disease and restless legs syndrome
Apexbio Technology LLC Ranolazine 2HCl 95635-56-6 10mg
Ranolazine 2HCl (CAS 95635-56-6) is a small molecule frequently utilized in cardiovascular research for its antianginal and antiarrhythmic activities It modulates cardiac metabolism by partially inhibiting fatty acid -oxidation thereby increasing reliance on glucose oxidation This metabolic shift is mediated through activation of pyruvate dehydrogenase in ischemic myocytes enhancing glucose utilization during myocardial ischemia Ranolazine 2HCl s ability to alter substrate preference and improve cellular energetics under hypoxic conditions supports its application in studies of cardiac ischemia arrhythmias and myocardial metabolism
Medchemexpress LLC Methyl 3-oxohexanoate | 30414-54-1 | 144.17 | 10 G
Methyl 3-oxohexanoate (Methyl Butyrylacetate) is an organic compound commonly used in the manufacture of fragrances, drugs, and other chemicals. It functions as a condensation, diazotization, and addition reagent, playing a catalytic role in various organic synthesis reactions and drug synthesis.
- Used in the food industry for products like juices, beer, and confectionery.
- Functions as a condensation reagent.
- Functions as a diazotization reagent.
- Functions as an addition reagent.
- Catalytic role in organic synthesis reactions.
- Useful in drug synthesis.
- Biochemical reagent for life science-related research.
Medchemexpress LLC Ym-244769 dihydrochloride | 1780390-65-9 | 516.39 | 25 MG
Ym-244769 dihydrochloride is a potent, selective, and orally active Na+/Ca2+ exchanger (NCX) inhibitor. It preferentially inhibits NCX3 and suppresses the unidirectional outward NCX current (Ca2+ entry mode), with IC50 values of 18 nM and 50 nM, respectively. This compound efficiently protects against hypoxia/reoxygenation-induced SH-SY5Y neuronal cell damage. It can also increase urine volume and urinary excretion of electrolytes in mice.
- Potent and selective Na+/Ca2+ exchanger (NCX) inhibitor.
- Preferentially inhibits NCX3.
- Suppresses unidirectional outward NCX current (Ca2+ entry mode).
- Protects against hypoxia/reoxygenation-induced neuronal cell damage.
- Increases urine volume and urinary excretion of electrolytes.
Apexbio Technology LLC GSK-LSD1 2HCl 2102933-95-7 100mg
GSK-LSD1 2HCl (CAS 2102933-95-7) is a selective irreversible inhibitor of lysine-specific demethylase 1A (LSD1) a flavin-dependent histone demethylase that modulates mono- and dimethylated lysine residues and is implicated in processes such as oocyte growth and tissue-specific differentiation GSK-LSD1 2HCl inhibits LSD1 with an IC50 of 16 nM and exhibits over 1000-fold selectivity against related FAD-utilizing enzymes including LSD2 MAO-A and MAO-B In cancer cell lines it demonstrates EC50 values below 5 nM for both gene expression modulation and growth inhibition GSK-LSD1 2HCl serves as a valuable chemical probe in epigenetics and cancer research